Table 3 Clinicopathological characteristics and treatment regimens of the 3,987 patients in the BCCA cohort
From: αB-crystallin expression in breast cancer is associated with brain metastasis
N | % | |
|---|---|---|
Age (years) | ||
<40 | 294 | 7 |
40–49 | 843 | 21 |
50–65 | 1,423 | 36 |
>65 | 1,427 | 36 |
Grade | ||
1 | 209 | 6 |
2 | 1,562 | 41 |
3 | 2,037 | 54 |
NA | 179 | |
Menstrual status at referral | ||
Pre-menopausal | 1,178 | 30 |
Post-menopausal | 2,717 | 70 |
NA | 92 | |
Nodal status | ||
Negative | 2,265 | 57 |
Positive | 1,714 | 43 |
NA | 8 | |
Lymphovascular invasion | ||
Negative | 2,105 | 55 |
Positive | 1,709 | 45 |
NA | 173 | |
Tumor size (cm) | ||
≤2 | 2,077 | 52 |
2–5 | 1,665 | 42 |
>5 | 221 | 6 |
NA | 24 | |
Initial Adjuvant Systemic Therapy | ||
None | 1,676 | 42 |
Tamoxifen only | 1,274 | 32 |
Chemotherapy only (AC, FAC or CMF) | 725 | 18 |
Tamoxifen and chemotherapy | 296 | 8 |
Other | 16 | |
